Wild-type transthyretin amyloidosis (ATTRwt-CA) accounted for the majority of cases, representing 76% (95% CI, 57%-89%) of CA diagnoses and a pooled prevalence of 11% among screened populations. Here, TTR is linked to amyloidosis.